EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effectiveness of Guselkumab for the Treatment of Moderate-to- Severe Psoriasis in Elderly Patients: A Retrospective, Real-World Multicenter Study in the Lazio Region

Giuseppe P A Gemma iD, Nicoletta Bernardini iD, Francesca Paola Sasso, Giacomo Caldarola, Eleonora De Luca iD, Maria Elisabetta Greco iD, Viviana Lora, Annamaria Mazzotta, Emanuele Miraglia, Diego Orsini, Gianluca Pagnanelli, Antonio Giovanni Richetta iD und 2 weitere

Clinics and Practice · 26.06.2026 · 16 (7) · 119

DOI: 10.3390/clinpract16070119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinics and Practice, online erschienen am 26.06.2026. Verfasst von Giuseppe P A Gemma und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Clinic, Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Guselkumab, a selective interleukin-23 inhibitor, is effective in moderate-to-severe plaque psoriasis, but real-world long-term data in elderly patients remain limited.

Objective

To evaluate the long-term effectiveness of guselkumab in elderly patients with moderate-to-severe psoriasis in a real-world setting.

Methods

This retrospective, multicenter study included 102 patients aged 65 years or older treated with guselkumab across seven Italian centers. PASI scores and PASI 75/90/100 responses were assessed as observed cases at weeks 4, 16, 28, and 52, and annually up to 4 years, with last-observation-carried-forward and non-responder imputation as sensitivity analyses. Subgroups by biologic experience and BMI were analyzed.

Results

Mean PASI decreased from 12.4 to 0.3 at week 52, remaining low through year 4 (p < 0.001). At week 52 and year 4, PASI 90 was achieved by 89.7% and 86.5%, and PASI 100 by 79.3% and 73.0%, respectively. Responses were comparable between biologic-naïve and biologic-experienced patients. Obese patients had higher baseline PASI; after adjustment for baseline severity, responses did not differ from non-obese patients.

Conclusions

Guselkumab was associated with high and durable PASI improvement in elderly patients, regardless of prior biologic exposure or body weight. The retrospective design and absence of systematic safety data warrant cautious interpretation.

Schlagwörter

Stichwörter der Autor:innen

effectivenesselderly patientsguselkumabpsoriasisreal world

Autor:innen und Institutionen

  • Dermatology Clinic, Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy.
  • Dermatology Unit, ASL Latina, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.
  • UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, 00168 Rome, Italy.
  • Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Clinical Dermatology Unit, San Gallicano Dermatological Institute IRCCS, 00144 Rome, Italy.
  • Dermatology Unit, A.O. San Camillo Forlanini, 00151 Rome, Italy.

ORCID-Profile: Giuseppe P A Gemma, Nicoletta Bernardini, Eleonora De Luca, Maria Elisabetta Greco, Antonio Giovanni Richetta, Nevena Skroza, Annunziata Dattola

Zitieren

APA

Gemma, G. P. A., Bernardini, N., Sasso, F. P., Caldarola, G., De Luca, E., Greco, M. E., Lora, V., Mazzotta, A., Miraglia, E., Orsini, D., Pagnanelli, G., Richetta, A. G., Skroza, N., & Dattola, A. (2026). Effectiveness of Guselkumab for the Treatment of Moderate-to- Severe Psoriasis in Elderly Patients: A Retrospective, Real-World Multicenter Study in the Lazio Region. Clinics and Practice, 16(7), 119. https://doi.org/10.3390/clinpract16070119

Vancouver

Gemma GPA, Bernardini N, Sasso FP, Caldarola G, De Luca E, Greco ME, et al. Effectiveness of Guselkumab for the Treatment of Moderate-to- Severe Psoriasis in Elderly Patients: A Retrospective, Real-World Multicenter Study in the Lazio Region. Clinics and Practice. 2026;16(7):119. doi:10.3390/clinpract16070119

BibTeX
@article{Gemma2026,
  author = {Gemma, Giuseppe P A and Bernardini, Nicoletta and Sasso, Francesca Paola and Caldarola, Giacomo and De Luca, Eleonora and Greco, Maria Elisabetta and Lora, Viviana and Mazzotta, Annamaria and Miraglia, Emanuele and Orsini, Diego and Pagnanelli, Gianluca and Richetta, Antonio Giovanni and Skroza, Nevena and Dattola, Annunziata},
  title = {Effectiveness of Guselkumab for the Treatment of Moderate-to- Severe Psoriasis in Elderly Patients: A Retrospective, Real-World Multicenter Study in the Lazio Region},
  journal = {Clinics and Practice},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {119},
  doi = {10.3390/clinpract16070119}
}
Kostenlos starten →